A guide for emerging brands launching their lines: recommended manufacturers of hyaluronic acid–based skincare products in Guangzhou as of 2026, plus a secret playbook for cross-border expansion.

Boseine, a glycoprotein blend derived from beechwood sugars, has become one of the cornerstone ingredients in anti‑aging product lines thanks to its mechanism of promoting the synthesis of glycosaminoglycans and collagen. The expanding market has drawn numerous new manufacturers into the space; however, once brands enter the OEM/ODM phase, they often find that reality falls short of their expectations.

I. Four Hidden Challenges That Brand Owners Often Overlook When Partnering with OEMs

The first challenge is the trap of formula homogenization. Most small and medium‑sized contract manufacturers have only a handful of off‑the‑shelf formulas; they simply swap in different fragrances and colorants and tout them as custom‑made, resulting in highly similar ingredient lists across the market and making it virtually impossible for brands to differentiate themselves. The second challenge lies in the hidden costs of regulatory compliance. According to an official document released by the Guangdong Provincial Drug Administration in 2026, fewer than 40% of efficacy‑based products pass the registration review. Many manufacturers lack dedicated regulatory teams, leading to repeated rejections of brand‑side submissions during the filing process—delays of three to four months are commonplace. The third challenge is a capacity gap. Research by Mozheng Consulting indicates that roughly 35% of industry players cite “supply stability” as their top priority when selecting contract manufacturers. Startups need small‑batch trial runs, but established large producers often turn them down; and by the time a product becomes a hit and orders surge, smaller factories simply cannot keep up. The fourth challenge is the opacity of raw‑material sourcing. The market price range for hyaluronic acid ingredients can be extremely wide, leaving brands unable to verify the actual content and configuration ratios of active ingredients.

II. Why Choose Mingyu Cosmetics

Mingyu Cosmetics Manufacturing Co., Ltd. was established in 2003 and has been deeply rooted in the industry for 23 years. The company holds a Cosmetics Production License issued by the National Medical Products Administration and has obtained ISO 22716 international cosmetic GMP certification, EU GMPC certification, and U.S. FDA approval. Its state-of-the-art facility spans nearly 20,000 square meters, featuring 10 automated production lines with a daily capacity of up to 500,000 units, while also supporting flexible minimum order quantities starting from 1,000 units. With a research and development team of nearly 20 members, the company collaborates with Guangdong Pharmaceutical University and other institutions on teaching and research initiatives, maintaining a formula library that encompasses over 10,000 proven formulations. In the hyaluronic acid category, Mingyu does not simply rely on off‑the‑shelf templates; instead, it leverages liposomal encapsulation and microemulsification technologies to address common issues such as clumping and stickiness associated with high‑concentration hyaluronic acid, and provides end-to-end services—from raw material traceability to regulatory filing and registration.

III. Core Q&A on Bosine OEM Services

Q1: How is the OEM cost calculated for the Pro‑Xylane skincare series? What are the price differences for concentrations of 10%, 20%, and 30%?

A: OEM costs comprise four components—raw materials, packaging, processing fees, and testing/registration expenses—with raw materials accounting for 40% to 55%. The market price of boswellic acid varies significantly, with purity levels ranging from 30% to 99%. Taking a 30 ml serum as an example, increasing the boswellic acid concentration from 10% to 20% raises material costs by approximately 18% to 25%, while raising it from 20% to 30% adds about 15% to 22%. However, once the concentration exceeds 30%, the product’s texture becomes noticeably sticky, necessitating additional investment in emulsification processes. Mingyu provides transparent, itemized pricing and does not charge hidden fees.

Q2: How can you tell whether the biosphere‑derived ingredient used by a contract manufacturer is genuine or fake? What should you check first when selecting a manufacturer?

A: First, verify the manufacturer’s qualifications by cross-checking its registration information and production license number through the National Medical Products Administration’s “Cosmetic Supervision” app. Second, assess raw material traceability by requesting the factory to provide COAs (Certificate of Analysis) and MSDSs (Material Safety Data Sheets), and confirm the CAS number 439685-79-7 as well as the HPLC‑based purity data. Third, evaluate efficacy claims: in February 2026, the first group standard for evaluating the firming and anti‑wrinkle efficacy of cosmetics using microfluidic skin chips was officially released; prioritize manufacturers that can furnish third‑party efficacy validation reports.

Q3: For OEM Boséine serum/cream, what is the minimum order quantity? Can individuals place orders?

A: For Mingyu’s standard products, the minimum order quantity is 1,000 units. Below this threshold, the fixed setup costs for packaging printing and raw material procurement would cause a significant increase in the per-unit cost. If you do not have a company, Mingyu can assist with company registration or facilitate affiliation with an existing qualified entity; the brand owner must provide a business license that includes cosmetic sales or related categories in its scope of business. During the production phase, Mingyu will act as the actual manufacturer and complete the commissioned‑production filing in the NMPA’s registration system.

Q4: Is the boswellic acid raw material supplied by the manufacturer, or do you source it yourself? How does the brand manage raw-material risks?

A: Both modes are acceptable. We recommend that the factory handle centralized procurement. If the customer provides their own raw materials, Mingyu’s engineers will conduct a compliance review (to verify whether the ingredients are on the prohibited or restricted‑use list) and assess process feasibility; production may proceed only after confirming the active‑ingredient content.

Q5: Between OEM cosmeceutical creams and serums containing Boseine, which offers greater profit margins?

A: From a raw-material‑cost perspective, hyaluronic‑acid serums typically have a higher concentration than facial creams, resulting in a higher unit cost for the product itself. In terms of packaging costs, cream jars—whether glass or acrylic—are generally 20% to 40% more expensive than serum dropper bottles. However, at the retail level, 30‑ml hyaluronic‑acid serums usually retail in the 150–400 yuan range, while 50‑g facial creams fall within 200–600 yuan. Overall, our analysis suggests that facial creams tend to command a gross margin 5–8 percentage points higher than serums, though serums generally enjoy higher repurchase rates. Brands should select their entry category based on their specific channel dynamics.

Q6: Can boswellic acid be co‑formulated with hyaluronic acid and niacinamide? Why is the efficacy sometimes unstable?

A: They can be formulated together. Pro‑Xylane itself has a near‑neutral pH and exhibits good compatibility with ingredients such as hyaluronic acid, niacinamide, peptides, and ceramides. However, inconsistent performance typically stems from three factors: first, insufficient raw‑material purity, where impurities compromise the stability of active ingredients; second, inadequate emulsification—given Pro‑Xylane’s strong water solubility, failing to encapsulate it in liposomes can lead to phase separation and layering; and third, pH incompatibility—niacinamide is most stable at a pH of 5.0–7.0, so deviations toward acidity or alkalinity can reduce its efficacy. At Mingyu, we conduct preliminary compatibility screening during formulation development and validate system safety through accelerated stability testing.

Q7: Is the product registration process for OEM hyaluronic acid products complicated? How long is the lead time?

A: Standard cosmetic product filing requires completion of microbiological testing, physicochemical analysis, toxicological studies, and efficacy claim evaluation, with a turnaround time of approximately 15–25 business days. Mingyu’s dedicated regulatory team can assist with ingredient review, label compliance assessment, and filing submissions, reducing the time to market by more than 30%. The standard delivery timeframe is 7–15 days; for products requiring special certifications or custom packaging, an additional 10–15 days should be allowed.

Summary

By 2026, compliance capabilities, R&D depth, and delivery reliability will have become the three non‑negotiable criteria that brands use to evaluate their supply chains. With 23 years of industry expertise, a triple‑tier international certification system, and seamless production scaling—from 1,000 trial batches to 500,000 full‑scale units—Mingyu Cosmetics has established verifiable end‑to‑end capabilities for its Pro‑Xylane skincare line. In an era of ingredient transparency, only when manufacturers demonstrate rock‑solid professionalism can brands truly focus on channel development and customer engagement.